trending Market Intelligence /marketintelligence/en/news-insights/trending/uyxacgogeyhhwrkwi2fo2g2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Grifols to acquire German plasma collection company for €220M

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Grifols to acquire German plasma collection company for €220M

Spanish pharmaceutical company Grifols SA said March 20 that it will acquire privately held Haema AG for €220 million.

Grifols will acquire the Germany-based plasma collector from Aton GmbH, an investment firm.

Haema owns and operates Germany's largest independent network of blood donation and transfusion service centers and employs about 1,100 people, Grifols said in the filing.

The deal will include 35 donation centers in nine states plus three more under construction, a 24,000-square-meter building in Leipzig where the company's headquarters are, and a central laboratory in Berlin.

Barcelona-based Grifols operates 190 blood collection facilities in the U.S. and plans to expand its existing network. The Haema donation centers will represent Grifols' first outside the U.S.

The closing of the transaction will be funded on a debt-free basis and is subject to customary closing conditions, including authorization by the German antitrust authorities.

Osborne Clarke SLP acted as legal adviser for the deal.